Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancerNicholas C. Turner, Susan Cleator|Annals of Oncology|2022Cited by 184